Nuclear transcription factor-kappaB as a target for cancer drug development.

Garg, A

Nuclear transcription factor-kappaB as a target for cancer drug development. [electronic resource] - Leukemia Jun 2002 - 1053-68 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review

0887-6924

10.1038/sj.leu.2402482 doi


Antineoplastic Agents--pharmacology
Drug Delivery Systems
Gene Deletion
Humans
Models, Biological
NF-kappa B--antagonists & inhibitors
Neoplasms--drug therapy